Related Experiment Videos

Role of Chlamydia pneumoniae in atherosclerosis

Caroline Watson1, Nicholas J Alp

  • 1Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Clinical Science (London, England : 1979)
|March 14, 2008
PubMed

Insights

Atherosclerosis, a cause of cardiovascular disease, may be linked to Chlamydia pneumoniae infection. This review examines 20 years of evidence on C. pneumoniae

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology
  • Pathogenesis Research

Background:

  • Atherosclerosis is a primary cause of global morbidity and mortality.
  • While genetics and environmental factors are known risks, other modifiable factors are potential therapeutic targets.
  • Infectious agents, specifically Chlamydia pneumoniae, are investigated for their role in atherosclerosis development.

Purpose of the Study:

  • To review experimental evidence on Chlamydia pneumoniae's role in atherosclerosis pathogenesis.
  • To identify potential therapeutic targets for atherosclerosis.
  • To suggest future research directions in this field.

Main Methods:

  • Comprehensive review of experimental studies over the past 20 years.
  • Analysis of evidence linking Chlamydia pneumoniae to atherosclerosis.
  • Synthesis of findings to evaluate the pathogen's contribution.

Main Results:

  • Evidence suggests a potential contributory role of Chlamydia pneumoniae in atherosclerosis.
  • The review consolidates findings from two decades of research.
  • Identified areas requiring further investigation into the C. pneumoniae-atherosclerosis link.

Conclusions:

  • Chlamydia pneumoniae remains a proposed factor in atherosclerosis pathogenesis.
  • Further research is needed to clarify the exact role and mechanisms.
  • Understanding this link may reveal new therapeutic strategies for cardiovascular disease.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview